Alterity Therapeutics (ASX:ATH) - Webinar Presentation

13/03/2023 10:20:00

This video is not supported on your device. Click here for the original version.

Dr David Stamler, CEO - Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.